Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and inborn errors of metabolism.
NASDAQ: AGIO$46.34 1.2 (2.52%)
RECENT NEWSRead more
UPCOMING EVENTSRead more
|There are currently no events scheduled.|